Moxifloxacin Injection, Solution
Product Images NDC 63323-850

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Moxifloxacin (NDC 63323-850). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mox06 0000 01

FDA Label Image

Mox06 0000 02

FDA Label Image

Mox06 0000 03

Mox06 0000 03
Moxifloxacin is an injected medication with a concentration of 400mg per 250 mL. It is meant for intravenous infusion only and should be used immediately once removed from the overwrap, and infused over a period of 60 minutes. The container closure is not made with any rubber. The product cannot be refrigerated as precipitation may occur. The dosage varies and further consultation is necessary. This medication is manufactured for Fresenius Kabi USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.